Product Information
AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT is a brand product labeled by Mannkind Corporation, priced at $10.3329 per EA under NDC 47918090218. Its NADAC has been published 184 times since Aug 21, 2019.
Manufacturer
Mannkind CorporationNDC
47918090218
Classification
Brand
Dosage Form
KIT
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Approval Type
Biologic (BLA)
FDA Application
BLA022472On Market Since
1/10/2017
Price Statistics
The NADAC for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT has been published 184 times since Aug 21, 2019, and over the history we have for it it has risen 49.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3329 per EA |
|---|---|
| All-time high | $10.3685 (Aug 12, 2026) |
| All-time low | $6.9261 (Aug 21, 2019) |
| 52-week high | $10.3685 |
| 52-week low | $10.0714 |
| Median price | $9.6594 |
| Average price | $9.1766 |
| Largest weekly change | +27.6% (Apr 17, 2024) |
| Weeks tracked | 184 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
The current National Average Drug Acquisition Cost (NADAC) for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT, manufactured by Mannkind Corporation, is $10.3329 per EA (NDC 47918090218), effective Aug 19, 2026.
How has the price of AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT changed over time?
Over the history we have for it, the NADAC for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT has risen 49.2%. It has been tracked across 184 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
Since Aug 21, 2019, the NADAC for AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT has ranged from a low of $6.9261 (Aug 21, 2019) to a high of $10.3685 (Aug 12, 2026), with a median of $9.6594 per EA.
Are there cheaper alternatives to AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT, is $7.8585 per EA — about 24% below AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT.
Who manufactures AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT?
AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT (NDC 47918090218) is labeled by Mannkind Corporation, and CMS classifies it as a brand product.